Chakma Justin sold SPRY
November 12, 2025 · Form 4 insider transaction
Chakma Justin sold 30,000 shares of ARS Pharmaceuticals, Inc. at $8.91 per share, a transaction worth $267.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
30,000
Price
$8.91
Total value
$267.4K
InsiderChakma Justin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after136,380
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $8.9119, and the range of prices was between $8.87 and $8.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.